Vimarsana
Biggest News Aggregation in the World

Page 48 - Shareholder Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shareholder Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shareholder Services Today - Breaking & Trending Today

Olympia Financial Group Inc. Plans Monthly Dividend of $0.45 (TSE:OLY) - Vimarsana News

Olympia Financial Group Inc. Plans Monthly Dividend of $0.45 (TSE:OLY)

Olympia Financial Group Inc. (TSE:OLY – Get Free Report) declared a monthly dividend on Wednesday, July 19th, TickerTech reports. Stockholders of record on Monday, July 31st will be paid a dividend of 0.45 per share by the health services provider on Monday, July 31st. This represents a $5.40 annualized dividend and a dividend yield of […]

Virtus Diversified Income & Convertible Fund Discloses Sources of Distribution – Section 19(a) Notice - Vimarsana News

Virtus Diversified Income & Convertible Fund Discloses Sources of Distribution – Section 19(a) Notice

Virtus Diversified Income & Convertible Fund previously announced the following monthly distribution on May 25, 2023: Ticker Amount of Distribution Ex-Date Record...

Virtus Artificial Intelligence & Technology Opportunities Fund Discloses Sources of Distribution – Section 19(a) Notice - Vimarsana News

Virtus Artificial Intelligence & Technology Opportunities Fund Discloses Sources of Distribution – Section 19(a) Notice

Virtus Artificial Intelligence & Technology Opportunities Fund previously announced the following monthly distribution on May 25, 2023: Ticker Amount of...

Infinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab in Patients with Squamous Cell Cancer of the Head and Neck - Vimarsana News

Infinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab in Patients with Squamous Cell Cancer of the Head and Neck

CAMBRIDGE - Infinity Pharmaceuticals, Inc. , a clinical-stage biotechnology company developing eganelisib, a first-in-class, oral, immuno-oncology macrophage reprogramming drug candidate, announced...

Olympia Financial Group (TSE:OLY) Trading Up 1.5% - Vimarsana News

Olympia Financial Group (TSE:OLY) Trading Up 1.5%

Olympia Financial Group Inc. (TSE:OLY – Get Free Report)’s share price was up 1.5% during mid-day trading on Monday . The stock traded as high as C$68.00 and last traded at C$68.00. Approximately 178 shares were traded during trading, a decline of 87% from the average daily volume of 1,421 shares. The stock had previously […]